A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
Titel:
A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
Auteur:
Backer, Vibeke Sjöbring, Ulf Sonne, Jesper Weiss, Anne Hostrup, Morten Johansen, Helle Krogh Becker, Victoria Sonne, David P. Balchen, Torben Jellingsø, Mads Sommer, Morten Otto Alexander